Alzheimer's Disease

US shipping from Canada supports access to prescription therapies used in cognitive decline care, including options often discussed with Alzheimer’s Disease treatment plans. This category groups medicines that may help with memory, thinking, and day-to-day function, plus therapies sometimes used for behavior, sleep, or mood changes that can occur alongside neurocognitive disorders. You can compare brands, dosage forms, and strengths, and you may see differences in titration steps, patch versus tablet use, and refill cadence; listings can change as stock and supplier status changes, so options may vary over time. If you are learning the basics, what is alzheimer’s disease commonly refers to a progressive neurodegenerative condition that affects memory and other cognitive skills, and it is often managed with supportive care, safety planning, and medications when appropriate.
What’s in This Category
This category includes prescription medicines used for Alzheimer’s and related dementias, as well as supportive treatments that clinicians may consider when symptoms affect safety or quality of life. Many shoppers start here after noticing alzheimer’s disease symptoms like short-term memory loss, confusion about time or place, or changes in judgment. These medicines do not cure the condition, but some may help with cognition or daily functioning for a period of time, especially when started and adjusted carefully. You can also use this page to orient to common medication classes and typical dosing patterns.
Two core medication classes appear often in care plans. Cholinesterase inhibitors (medicines that help increase acetylcholine, a memory-related brain chemical) are commonly used in mild to moderate disease. NMDA receptor antagonists (medicines that modulate glutamate signaling) may be used in moderate to severe stages, sometimes alongside a cholinesterase inhibitor. Product pages can help you compare immediate-release versus extended-release options, as well as oral tablets, oral solutions, and transdermal patches that can support adherence. If swallowing is difficult or routine is complex, a patch option can be worth discussing with a prescriber.
This category also includes some medicines used off-label for agitation, hallucinations, or sleep disruption. Those uses require extra caution, especially in older adults, due to side effects and drug interactions. If you are also tracking stage progression, the resource hub can add context through education pages and caregiver-focused articles.
How to Choose for alzheimer’s disease treatment
Start by matching the medication class to the goal of care and the stage of impairment. A prescriber may choose a cholinesterase inhibitor early, then add or switch therapies as symptoms progress or side effects appear. Focus on dosage form first, because adherence often matters more than small dose differences. For example, a once-daily tablet may fit a simple routine, while a patch may help when nausea limits oral dosing or when pill administration is unreliable.
Next, compare strengths and titration steps. Many options start at a lower dose and increase gradually, which can reduce side effects like nausea, dizziness, or sleep changes. Check storage and handling basics before you decide on a form. Patches need clean, dry skin and consistent rotation, and oral solutions require careful measuring. If you take other medications, review interaction risks with a pharmacist, including anticholinergic drugs that can worsen confusion.

Common mistake: switching strengths too quickly without tolerability checks.
Common mistake: mixing look-alike tablets and missing doses in shared pill organizers.
Common mistake: overlooking dehydration, infection, or pain as causes of sudden confusion.

Education can help you discuss options clearly at appointments. The article at Alzheimer’s treatment options outlines common approaches, including medication add-ons and non-drug supports like routines and environmental safety steps.
Popular Options
Several well-known products in this category focus on cognition and function. When comparing alzheimer’s disease treatment drugs, look at the active ingredient, dosage form, titration schedule, and whether the product is a brand or a generic equivalent. You may also want to note refill quantities and whether the medicine is typically taken once daily or twice daily. These details can affect caregiver workload and consistency, which often drives real-world results.
Donepezil is a commonly used cholinesterase inhibitor, often taken once daily. You can review strengths and presentations on the donepezil tablets page, including typical step-up dosing patterns described on the label. Memantine is an NMDA receptor antagonist used in moderate to severe impairment, and the memantine listing can help you compare formulations and strengths. If adherence is difficult or gastrointestinal side effects limit oral therapy, a transdermal option like rivastigmine patch may be part of a care plan.
Some people also use another cholinesterase inhibitor, and the galantamine product page supports comparisons across strengths and dosage forms. In select cases, clinicians may address distressing behavioral symptoms with carefully monitored therapy, and quetiapine may appear in treatment histories for agitation or sleep disruption. These supportive medicines can carry meaningful risks, so they should be reviewed regularly and used at the lowest effective dose when prescribed.
Related Conditions & Uses
Many shoppers arrive here while trying to understand overlap among memory disorders and broader brain health needs. Alzheimer’s is a specific diagnosis within the broader umbrella of dementia, and alzheimer’s disease vs dementia comparisons often focus on cause and pattern of decline rather than severity alone. The Dementia hub can help you explore other etiologies, common symptoms, and supportive care themes, including safety and caregiver planning.
Vascular contributions to cognitive impairment are also common, especially with a history of stroke or long-standing vascular risk. The Vascular Dementia page covers how cerebrovascular disease can affect thinking and function, and why blood pressure, cholesterol, and diabetes management matter for overall brain health. Many people find it helpful to read a clear comparison before medication discussions, and Dementia vs Alzheimer’s summarizes key differences in plain language.

Mixed presentations can occur, so clinicians may treat cognition while also reducing vascular risks.
Depression, anxiety, poor sleep, and medication side effects can mimic cognitive decline.
Sudden worsening can signal infection, dehydration, or drug interactions that need prompt care.

If you are documenting diagnoses for records, coding may appear on claims and charts. Clinicians may reference ICD-10 terminology such as the Alzheimer’s family of codes, which can include details by onset and features.
Authoritative Sources
Use these sources for neutral background on medicines, diagnosis, and terminology. For coding discussions, alzheimer’s disease icd-10 conventions can differ by setting, so confirm codes with a clinical office or billing specialist when accuracy matters.

National Institute on Aging explains Alzheimer’s basics and care: NIA Alzheimer’s Health Topics.
FDA guidance on safe medicine use and labeling basics: FDA Using Medicines Safely.
CDC ICD-10-CM browsing tool for code categories: CDC ICD-10-CM.

This content is for informational purposes only and is not a substitute for professional medical advice.